View in EDS HTML Full Text PDF Full Text

The cost of drug repurposing: parallel economic evaluation of mirtazapine for severe breathlessness in the multinational BETTER-B trial.

Saved in:
Bibliographic Details
Title: The cost of drug repurposing: parallel economic evaluation of mirtazapine for severe breathlessness in the multinational BETTER-B trial.
Authors: May, Peter1,2 (AUTHOR) peter.d.may@kcl.ac.uk, Normand, Charles1,2 (AUTHOR), Oluyase, Adejoke O.1 (AUTHOR), Smith, Samantha2 (AUTHOR), Brown, Sarah T.3 (AUTHOR), Maddocks, Matthew1 (AUTHOR), Costantini, Massimo1 (AUTHOR), Bajwah, Sabrina1,4 (AUTHOR), Kahnert, Kathrin5,6 (AUTHOR), Simon, Steffen T.7 (AUTHOR), Ryan, Karen8 (AUTHOR), Currow, David C.9 (AUTHOR), Johnson, Miriam J.10 (AUTHOR), Hart, Simon P.11 (AUTHOR), Krajnik, Małgorzata12 (AUTHOR), Tanzi, Silvia13 (AUTHOR), Bolton, Charlotte E.14 (AUTHOR), Janowiak, Piotr15 (AUTHOR), Turola, Elena13 (AUTHOR), Jolley, Caroline J.4,16 (AUTHOR)
Source: BMC Health Services Research. 11/4/2025, Vol. 25 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14726963
DOI:10.1186/s12913-025-13605-9